Skip to main content

DEXTROAMPHETAMINE-AMPHETAMINE

Tracking # 20-1060110

$99999.00

There are no ratings for this course

Learn more
CE Broker Reporting Reported automatically
Method Computer-Based Training

Course overview

DEXTROAMPHETAMINE/AMPHETAMINE BELONGS TO A CLASS OF DRUGS KNOWN AS CENTRAL NERVOUS SYSTEM STIMULANTS. THE DRUG ENFORCEMENT ADMINISTRATION/FOOD AND DRUG ADMINISTRATION CLASSIFIES THESE MEDICATIONS AS SCHEDULE II DRUGS WITH HIGH POTENTIAL FOR ABUSE IN THE UNITED STATES. IMMEDIATE-RELEASE AND SUSTAINED-RELEASE AMPHETAMINE MEDICATIONS ARE FDA-APPROVED TO TREAT ADHD AND NARCOLEPSY IN BOTH ADULT AND PEDIATRIC POPULATIONS. NON-FDA-APPROVED CLINICAL USES FOR DEXTROAMPHETAMINE/AMPHETAMINE INCLUDE CEREBROVASCULAR ACCIDENTS. THIS ACTIVITY WILL HIGHLIGHT THE MECHANISM OF ACTION, ADVERSE EVENT PROFILE, APPROVED AND OFF-LABEL USES, DOSING, PHARMACODYNAMICS, PHARMACOKINETICS, MONITORING, RELEVANT INTERACTIONS OF DEXTROAMPHETAMINE/AMPHETAMINE, PERTINENT FOR INTERPROFESSIONAL TEAM MEMBERS USING THESE MEDICATIONS FOR THEIR INTENDED INDICATIONS.

Subject areas

This course counts toward the state boards and subject areas below.

Bahamas Medical Council

Specialty Medical Practitioner

1h General Medicine

Louisiana State Board of Medical Examiners - Physicians & Surgeons

Physician & Surgeon

1h Category I CME

Mississippi State Board of Medical Licensure

Medical Doctor

1h AMA Category I

Physician Assistant

1h AMA Category I

State Medical Board of Ohio

Doctor of Medicine

1h AMA Category I